{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:03:27Z","timestamp":1786982607883,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T00:00:00Z","timestamp":1719273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bacterial infections pose a life-threatening complication in patients with decompensated liver cirrhosis and acute-on-chronic liver failure. An increasing prevalence of infections caused by multidrug-resistant organisms (MDROs) has been observed in these patients, significantly impacting prognosis. A growing body of evidence has identified the most common risk factors for such infections, enabling the development of preventive strategies and therapeutic interventions. MDRO infections may also occur after liver transplantation (most commonly in the early post-operative phase), affecting both graft and patient survival. This review provides an overview of MDRO infections before and after liver transplantation, discussing epidemiological aspects, risk factors, prevention strategies, and novel therapeutic approaches. Furthermore, it examines the implications of MDRO infections in the context of prioritizing liver transplantation for the most severe patients, such as those with acute-on-chronic liver failure.<\/jats:p>","DOI":"10.1007\/s13304-024-01903-6","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:08:15Z","timestamp":1719324495000},"page":"2521-2529","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multidrug-resistant bacterial infections in the liver transplant setting"],"prefix":"10.1007","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3248-2038","authenticated-orcid":false,"given":"Alberto","family":"Ferrarese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Senzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lolita","family":"Sasset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Cillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Burra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,25]]},"reference":[{"issue":"1","key":"1903_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","volume":"14","author":"P Strnad","year":"2017","unstructured":"Strnad P, Tacke F, Koch A, Trautwein C (2017) Liver - guardian, modifier and target of sepsis. Nat Rev Gastroenterol Hepatol 14(1):55\u201366. https:\/\/doi.org\/10.1038\/nrgastro.2016.168","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1903_CR2","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41575-021-00520-7","volume":"19","author":"A Albillos","year":"2022","unstructured":"Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, \u00c1lvarez-Mon M (2022) Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 19(2):112\u2013134. https:\/\/doi.org\/10.1038\/s41575-021-00520-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1903_CR3","doi-asserted-by":"publisher","unstructured":"Simonetto DA, Piccolo Serafim L, Gallo de Moraes A, Gajic O, Kamath PS (2019) Management of sepsis in patients with cirrhosis: current evidence and practical approach. Hepatology 70(1):418\u2013428. https:\/\/doi.org\/10.1002\/hep.30412","DOI":"10.1002\/hep.30412"},{"issue":"5","key":"1903_CR4","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jhep.2016.08.006","volume":"65","author":"J Fern\u00e1ndez","year":"2016","unstructured":"Fern\u00e1ndez J, Bert F, Nicolas-Chanoine MH (2016) The challenges of multi-drug-resistance in hepatology. J Hepatol 65(5):1043\u20131054. https:\/\/doi.org\/10.1016\/j.jhep.2016.08.006","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"1903_CR5","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/j.jhep.2020.11.010","volume":"75","author":"J Fern\u00e1ndez","year":"2021","unstructured":"Fern\u00e1ndez J, Piano S, Bartoletti M, Wey EQ (2021) Management of bacterial and fungal infections in cirrhosis: The MDRO challenge. J Hepatol 75(Suppl 1):S101\u2013S117. https:\/\/doi.org\/10.1016\/j.jhep.2020.11.010","journal-title":"J Hepatol"},{"issue":"24","key":"1903_CR6","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMra2021808","volume":"384","author":"JS Bajaj","year":"2021","unstructured":"Bajaj JS, Kamath PS, Reddy KR (2021) The evolving challenge of infections in cirrhosis. N Engl J Med 384(24):2317\u20132330. https:\/\/doi.org\/10.1056\/NEJMra2021808","journal-title":"N Engl J Med"},{"issue":"2","key":"1903_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4254\/wjh.v10.i2.222","volume":"10","author":"A Ferrarese","year":"2018","unstructured":"Ferrarese A, Zanetto A, Becchetti C et al (2018) Management of bacterial infection in the liver transplant candidate. World J Hepatol 10(2):222\u2013230. https:\/\/doi.org\/10.4254\/wjh.v10.i2.222","journal-title":"World J Hepatol"},{"issue":"2","key":"1903_CR8","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jhep.2020.07.046","volume":"74","author":"F Wong","year":"2021","unstructured":"Wong F, Piano S, Singh V et al (2021) Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure. J Hepatol 74(2):330\u2013339. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.046","journal-title":"J Hepatol"},{"key":"1903_CR9","doi-asserted-by":"publisher","unstructured":"Bajaj JS, O\u2019Leary JG, Tandon P, et al (2019) Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis. Am J Gastroenterol 114(7):1091\u20131100. https:\/\/doi.org\/10.14309\/ajg.0000000000000280","DOI":"10.14309\/ajg.0000000000000280"},{"issue":"6","key":"1903_CR10","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/ajt.13136","volume":"15","author":"M Giannella","year":"2015","unstructured":"Giannella M, Bartoletti M, Morelli MC et al (2015) Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae after liver transplantation: the importance of pre- and posttransplant colonization. Am J Transplant 15(6):1708\u20131715. https:\/\/doi.org\/10.1111\/ajt.13136","journal-title":"Am J Transplant"},{"issue":"4","key":"1903_CR11","doi-asserted-by":"publisher","first-page":"e955","DOI":"10.1093\/cid\/ciab109","volume":"73","author":"M Giannella","year":"2021","unstructured":"Giannella M, Freire M, Rinaldi M et al (2021) Development of a risk prediction model for carbapenem-resistant enterobacteriaceae infection after liver transplantation: a multinational cohort study. Clin Infect Dis 73(4):e955\u2013e966. https:\/\/doi.org\/10.1093\/cid\/ciab109","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1903_CR12","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","volume":"156","author":"S Piano","year":"2019","unstructured":"Piano S, Singh V, Caraceni P et al (2019) Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide. Gastroenterology 156(5):1368-1380.e10. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.005","journal-title":"Gastroenterology"},{"issue":"3","key":"1903_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","volume":"70","author":"J Fern\u00e1ndez","year":"2019","unstructured":"Fern\u00e1ndez J, Prado V, Trebicka J et al (2019) Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. J Hepatol 70(3):398\u2013411. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.027","journal-title":"J Hepatol"},{"issue":"1","key":"1903_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/liv.13195","volume":"37","author":"F Salerno","year":"2017","unstructured":"Salerno F, Borzio M, Pedicino C et al (2017) The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicentre prospective study. Liver Int 37(1):71\u201379. https:\/\/doi.org\/10.1111\/liv.13195","journal-title":"Liver Int"},{"issue":"8","key":"1903_CR15","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1002\/lt.25479","volume":"25","author":"A Ferrarese","year":"2019","unstructured":"Ferrarese A, Vitale A, Sgarabotto D et al (2019) Outcome of a first episode of bacterial infection in candidates for liver transplantation. Liver Transpl 25(8):1187\u20131197. https:\/\/doi.org\/10.1002\/lt.25479","journal-title":"Liver Transpl"},{"issue":"2","key":"1903_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000038","volume":"7","author":"M Kim","year":"2023","unstructured":"Kim M, Cardoso FS, Pawlowski A et al (2023) The impact of multidrug-resistant microorganisms on critically ill patients with cirrhosis in the intensive care unit: a cohort study. Hepatol Commun. 7(2):e0038. https:\/\/doi.org\/10.1097\/HC9.0000000000000038","journal-title":"Hepatol Commun."},{"issue":"5","key":"1903_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.jhep.2021.12.042","volume":"76","author":"V Prado","year":"2022","unstructured":"Prado V, Hern\u00e1ndez-Tejero M, M\u00fccke MM et al (2022) Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis. J Hepatol 76(5):1079\u20131089. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.042","journal-title":"J Hepatol"},{"issue":"8","key":"1903_CR18","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000223","volume":"11","author":"MM M\u00fccke","year":"2020","unstructured":"M\u00fccke MM, M\u00fccke VT, Graf C et al (2020) Efficacy of norfloxacin prophylaxis to prevent spontaneous bacterial peritonitis: a systematic review and meta-analysis. Clin Transl Gastroenterol 11(8):e00223. https:\/\/doi.org\/10.14309\/ctg.0000000000000223","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"1903_CR19","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","volume":"155","author":"R Moreau","year":"2018","unstructured":"Moreau R, Elkrief L, Bureau C et al (2018) Effects of long-term norfloxacin therapy in patients with advanced cirrhosis. Gastroenterology. 155(6):1816-1827.e9. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.026","journal-title":"Gastroenterology."},{"issue":"5","key":"1903_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127448","volume":"10","author":"M Merli","year":"2015","unstructured":"Merli M, Lucidi C, Di Gregorio V et al (2015) The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey. PLoS One 10(5):e0127448. https:\/\/doi.org\/10.1371\/journal.pone.0127448","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"1903_CR21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","volume":"56","author":"J Fern\u00e1ndez","year":"2012","unstructured":"Fern\u00e1ndez J, Gustot T (2012) Management of bacterial infections in cirrhosis. J Hepatol 56(Suppl 1):S1-12. https:\/\/doi.org\/10.1016\/S0168-8278(12)60002-6","journal-title":"J Hepatol"},{"issue":"4","key":"1903_CR22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10096-023-04572-2","volume":"42","author":"S Marciano","year":"2023","unstructured":"Marciano S, Gutierrez-Acevedo MN, Barbero S et al (2023) Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections. Eur J Clin Microbiol Infect Dis 42(4):481\u2013491. https:\/\/doi.org\/10.1007\/s10096-023-04572-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1903_CR23","doi-asserted-by":"publisher","unstructured":"EASL (2023) Clinical Practice Guidelines on acute-on-chronic liver failure. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.021","DOI":"10.1016\/j.jhep.2023.04.021"},{"issue":"11","key":"1903_CR24","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Crit Care Med 49(11):e1063\u2013e1143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337","journal-title":"Crit Care Med"},{"issue":"11","key":"1903_CR25","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1002\/lt.25621","volume":"25","author":"R Martin Mateos","year":"2019","unstructured":"Martin Mateos R, Albillos A (2019) Sepsis in patients with cirrhosis awaiting liver transplantation: new trends and management. Liver Transpl 25(11):1700\u20131709. https:\/\/doi.org\/10.1002\/lt.25621","journal-title":"Liver Transpl"},{"issue":"5","key":"1903_CR26","doi-asserted-by":"publisher","first-page":"546.e1","DOI":"10.1016\/j.cmi.2017.08.001","volume":"24","author":"M Bartoletti","year":"2018","unstructured":"Bartoletti M, Giannella M, Lewis R et al (2018) A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. Clin Microbiol Infect 24(5):546.e1-546.e8. https:\/\/doi.org\/10.1016\/j.cmi.2017.08.001","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"1903_CR27","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00134-023-07149-x","volume":"49","author":"G Perricone","year":"2023","unstructured":"Perricone G, Artzner T, De Martin E, Jalan R, Wendon J, Carbone M (2023) Intensive care management of acute-on-chronic liver failure. Intensive Care Med 49(8):903\u2013921. https:\/\/doi.org\/10.1007\/s00134-023-07149-x","journal-title":"Intensive Care Med"},{"issue":"10","key":"1903_CR28","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","volume":"67","author":"J Fern\u00e1ndez","year":"2018","unstructured":"Fern\u00e1ndez J, Acevedo J, Wiest R et al (2018) Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis. Gut 67(10):1870\u20131880. https:\/\/doi.org\/10.1136\/gutjnl-2017-314240","journal-title":"Gut"},{"issue":"5","key":"1903_CR29","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1053\/j.gastro.2018.12.007","volume":"156","author":"V Sundaram","year":"2019","unstructured":"Sundaram V, Jalan R, Wu T et al (2019) Factors associated with survival of patients with severe acute-on-chronic liver failure before and after liver transplantation. Gastroenterology 156(5):1381-1391.e3. https:\/\/doi.org\/10.1053\/j.gastro.2018.12.007","journal-title":"Gastroenterology"},{"issue":"4","key":"1903_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jhep.2017.06.009","volume":"67","author":"F Artru","year":"2017","unstructured":"Artru F, Louvet A, Ruiz I et al (2017) Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3. J Hepatol 67(4):708\u2013715. https:\/\/doi.org\/10.1016\/j.jhep.2017.06.009","journal-title":"J Hepatol"},{"issue":"9","key":"1903_CR31","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1111\/ajt.15852","volume":"20","author":"T Artzner","year":"2020","unstructured":"Artzner T, Michard B, Weiss E et al (2020) Liver transplantation for critically ill cirrhotic patients: Stratifying utility based on pretransplant factors. Am J Transplant. 20(9):2437\u20132448. https:\/\/doi.org\/10.1111\/ajt.15852","journal-title":"Am J Transplant."},{"issue":"6","key":"1903_CR32","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jhep.2021.12.003","volume":"76","author":"JS Bajaj","year":"2022","unstructured":"Bajaj JS, Ng SC, Schnabl B (2022) Promises of microbiome-based therapies. J Hepatol 76(6):1379\u20131391. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.003","journal-title":"J Hepatol"},{"issue":"1","key":"1903_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.trre.2017.07.001","volume":"32","author":"JM Aguado","year":"2018","unstructured":"Aguado JM, Silva JT, Fern\u00e1ndez-Ruiz M et al (2018) Management of multidrug resistant Gram-negative bacilli infections in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations. Transplant Rev (Orlando) 32(1):36\u201357. https:\/\/doi.org\/10.1016\/j.trre.2017.07.001","journal-title":"Transplant Rev (Orlando)"},{"key":"1903_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.02.023","author":"R Martin-Mateos","year":"2024","unstructured":"Martin-Mateos R, Mart\u00ednez-Arenas L, Carvalho-Gomes \u00c1 et al (2024) Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors. J Hepatol. https:\/\/doi.org\/10.1016\/j.jhep.2024.02.023","journal-title":"J Hepatol."},{"issue":"6","key":"1903_CR35","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11908-016-0526-9","volume":"18","author":"JD Lewis","year":"2016","unstructured":"Lewis JD, Sifri CD (2016) Multidrug-resistant bacterial donor-derived infections in solid organ transplantation. Curr Infect Dis Rep 18(6):18. https:\/\/doi.org\/10.1007\/s11908-016-0526-9","journal-title":"Curr Infect Dis Rep"},{"issue":"9","key":"1903_CR36","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1111\/ajt.15488","volume":"19","author":"JA Anesi","year":"2019","unstructured":"Anesi JA, Blumberg EA, Han JH et al (2019) Risk factors for multidrug-resistant organisms among deceased organ donors. Am J Transplant 19(9):2468\u20132478. https:\/\/doi.org\/10.1111\/ajt.15488","journal-title":"Am J Transplant"},{"issue":"1","key":"1903_CR37","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/ajt.15566","volume":"20","author":"F Procaccio","year":"2020","unstructured":"Procaccio F, Masiero L, Vespasiano F et al (2020) Organ donor screening for carbapenem-resistant gram-negative bacteria in Italian intensive care units: the DRIn study. Am J Transplant 20(1):262\u2013273. https:\/\/doi.org\/10.1111\/ajt.15566","journal-title":"Am J Transplant"},{"issue":"1","key":"1903_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13783","volume":"24","author":"JA Anesi","year":"2022","unstructured":"Anesi JA, Blumberg EA, Han JH et al (2022) Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes. Transpl Infect Dis 24(1):e13783. https:\/\/doi.org\/10.1111\/tid.13783","journal-title":"Transpl Infect Dis"},{"key":"1903_CR39","doi-asserted-by":"publisher","unstructured":"Wolfe CR, Ison MG, Practice AIDCo (2019) Donor-derived infections: guidelines from the american society of transplantation infectious diseases community of practice. Clin Transplant 33(9):e13547. https:\/\/doi.org\/10.1111\/ctr.13547","DOI":"10.1111\/ctr.13547"},{"issue":"3","key":"1903_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.15403\/jgld-212","volume":"28","author":"K Friedrich","year":"2019","unstructured":"Friedrich K, Krempl J, Schamoni S et al (2019) Multidrug-resistant bacteria and disease progression in patients with end-stage liver disease and after liver transplantation. J Gastrointestin Liver Dis 28(3):303\u2013310. https:\/\/doi.org\/10.15403\/jgld-212","journal-title":"J Gastrointestin Liver Dis"},{"issue":"1","key":"1903_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.15173","volume":"38","author":"GT Lemos","year":"2024","unstructured":"Lemos GT, Terrabuio DRB, Nunes NN et al (2024) Pre-transplant multidrug-resistant infections in liver transplant recipients-epidemiology and impact on transplantation outcome. Clin Transplant 38(1):e15173. https:\/\/doi.org\/10.1111\/ctr.15173","journal-title":"Clin Transplant"},{"issue":"12","key":"1903_CR42","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.cmi.2019.04.014","volume":"25","author":"M Giannella","year":"2019","unstructured":"Giannella M, Bartoletti M, Campoli C et al (2019) The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Clin Microbiol Infect 25(12):1525\u20131531. https:\/\/doi.org\/10.1016\/j.cmi.2019.04.014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1903_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/TP.0000000000001620","volume":"101","author":"MP Freire","year":"2017","unstructured":"Freire MP, Oshiro IC, Pierrotti LC et al (2017) Carbapenem-resistant enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 101(4):811\u2013820. https:\/\/doi.org\/10.1097\/TP.0000000000001620","journal-title":"Transplantation."},{"issue":"5","key":"1903_CR44","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1002\/lt.24389","volume":"22","author":"MP Freire","year":"2016","unstructured":"Freire MP, Pierrotti LC, Oshiro IC et al (2016) Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes. Liver Transpl. 22(5):615\u201326. https:\/\/doi.org\/10.1002\/lt.24389","journal-title":"Liver Transpl."},{"issue":"8","key":"1903_CR45","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/ajt.12784","volume":"14","author":"PD Ziakas","year":"2014","unstructured":"Ziakas PD, Pliakos EE, Zervou FN, Knoll BM, Rice LB, Mylonakis E (2014) MRSA and VRE colonization in solid organ transplantation: a meta-analysis of published studies. Am J Transplant 14(8):1887\u20131894. https:\/\/doi.org\/10.1111\/ajt.12784","journal-title":"Am J Transplant"},{"issue":"4","key":"1903_CR46","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/lt.23374","volume":"18","author":"JS Kalpoe","year":"2012","unstructured":"Kalpoe JS, Sonnenberg E, Factor SH et al (2012) Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl 18(4):468\u2013474. https:\/\/doi.org\/10.1002\/lt.23374","journal-title":"Liver Transpl"},{"issue":"12","key":"1903_CR47","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/lt.24207","volume":"21","author":"MR Pereira","year":"2015","unstructured":"Pereira MR, Scully BF, Pouch SM et al (2015) Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl 21(12):1511\u20131519. https:\/\/doi.org\/10.1002\/lt.24207","journal-title":"Liver Transpl"},{"issue":"3","key":"1903_CR48","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.idc.2018.04.004","volume":"32","author":"M Bartoletti","year":"2018","unstructured":"Bartoletti M, Giannella M, Tedeschi S, Viale P (2018) Multidrug-resistant bacterial infections in solid organ transplant candidates and recipients. Infect Dis Clin North Am. 32(3):551\u2013580. https:\/\/doi.org\/10.1016\/j.idc.2018.04.004","journal-title":"Infect Dis Clin North Am."},{"issue":"2","key":"1903_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1432-2277.2009.00974.x","volume":"23","author":"E Vandecasteele","year":"2010","unstructured":"Vandecasteele E, De Waele J, Vandijck D et al (2010) Antimicrobial prophylaxis in liver transplant patients\u2013a multicenter survey endorsed by the European Liver and Intestine Transplant Association. Transpl Int 23(2):182\u2013190. https:\/\/doi.org\/10.1111\/j.1432-2277.2009.00974.x","journal-title":"Transpl Int"},{"key":"1903_CR50","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14238","author":"C Bonazzetti","year":"2024","unstructured":"Bonazzetti C, Rinaldi M, Cosentino F et al (2024) Survey on the approach to antibiotic prophylaxis in liver and kidney transplant recipients colonized with \u201cdifficult to treat\u201d Gram-negative bacteria. Transpl Infect Dis. https:\/\/doi.org\/10.1111\/tid.14238","journal-title":"Transpl Infect Dis."},{"issue":"3","key":"1903_CR51","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.trre.2018.04.001","volume":"32","author":"U Cillo","year":"2018","unstructured":"Cillo U, Bechstein WO, Berlakovich G et al (2018) Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression. Transplant Rev (Orlando) 32(3):142\u2013150. https:\/\/doi.org\/10.1016\/j.trre.2018.04.001","journal-title":"Transplant Rev (Orlando)"},{"key":"1903_CR52","doi-asserted-by":"publisher","unstructured":"Pouch SM, Patel G, Practice AIDCo (2019) Multidrug-resistant Gram-negative bacterial infections in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 33(9):e13594. https:\/\/doi.org\/10.1111\/ctr.13594","DOI":"10.1111\/ctr.13594"},{"issue":"7","key":"1903_CR53","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/lt.20108","volume":"10","author":"N Safdar","year":"2004","unstructured":"Safdar N, Said A, Lucey MR (2004) The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and meta-analysis. Liver Transpl 10(7):817\u2013827. https:\/\/doi.org\/10.1002\/lt.20108","journal-title":"Liver Transpl"},{"key":"1903_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006660.pub3","author":"KS Gurusamy","year":"2014","unstructured":"Gurusamy KS, Nagendran M, Davidson BR (2014) Methods of preventing bacterial sepsis and wound complications after liver transplantation. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD006660.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"1903_CR55","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijantimicag.2013.08.008","volume":"42","author":"C L\u00fcbbert","year":"2013","unstructured":"L\u00fcbbert C, Faucheux S, Becker-Rux D et al (2013) Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents 42(6):565\u2013570. https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.08.008","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"1903_CR56","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/tid.12235","volume":"16","author":"E Katchman","year":"2014","unstructured":"Katchman E, Marquez M, Bazerbachi F et al (2014) A comparative study of the use of selective digestive decontamination prophylaxis in living-donor liver transplant recipients. Transpl Infect Dis 16(4):539\u2013547. https:\/\/doi.org\/10.1111\/tid.12235","journal-title":"Transpl Infect Dis"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13304-024-01903-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-024-01903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T09:11:16Z","timestamp":1732698676000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13304-024-01903-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,25]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1903"],"URL":"https:\/\/doi.org\/10.1007\/s13304-024-01903-6","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,25]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no competing interests exist.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable clinical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}